National Health Investors, Inc. (NHI): insider & executive buying
National Health Investors, Inc. · Real Estate · ref. ETF XLRE · price $72.56
In short — 2 insiders bought National Health Investors, Inc. over ~6 months (2 buys, total $167k, latest Jun 15, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are National Health Investors, Inc.'s executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$72.56-6.6% over range
Aug 28, 25low $68.32 · high $91.02Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
60% recommend buying · 5 analysts
Latest insider buys on National Health Investors, Inc.
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Jun 15, 26 | McCabe Robert A Jr | Dir | 890 | $64k |
| Jun 5, 26 | Mendelsohn D. Eric | CEO, Pres | 1,500 | $103k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have National Health Investors, Inc.'s executives bought shares recently?
2 National Health Investors, Inc. insider(s) bought $167k over ~6 months (latest Jun 15, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for NHI?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about National Health Investors, Inc.? The JPI assistant answers using our backtest data.
Keep exploring National Health Investors, Inc.